Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Antipyrine measurement |
Has measured component (attribute) |
False |
Phenazone |
Inferred relationship |
Some |
|
Aminophenazone poisoning |
Causative agent (attribute) |
False |
Phenazone |
Inferred relationship |
Some |
|
Antipyrine measurement |
Component |
True |
Phenazone |
Inferred relationship |
Some |
1 |
Antipyrine + benzocaine 5.4%wv/1.442%wv solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenazone |
Inferred relationship |
Some |
|
Product containing phenazone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenazone |
Inferred relationship |
Some |
1 |
Product containing benzocaine and phenazone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenazone |
Inferred relationship |
Some |
2 |
Product containing benzocaine and phenazone and phenylephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenazone |
Inferred relationship |
Some |
3 |
Antipyrine + benzocaine + glycerin 54mg/14mg/1cc solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenazone |
Inferred relationship |
Some |
|
Aminophenazone poisoning |
Causative agent (attribute) |
False |
Phenazone |
Inferred relationship |
Some |
|
Dichlorophenazone |
Is a |
False |
Phenazone |
Inferred relationship |
Some |
|
Product containing only benzocaine and phenazone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenazone |
Inferred relationship |
Some |
2 |
Benzocaine and phenazone and phenylephrine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenazone |
Inferred relationship |
Some |
3 |
Product containing only phenazone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenazone |
Inferred relationship |
Some |
1 |
Product containing precisely phenazone 50 milligram/1 milliliter conventional release solution for ear drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Phenazone |
Inferred relationship |
Some |
1 |
Product containing precisely phenazone 50 milligram/1 milliliter conventional release solution for ear drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Phenazone |
Inferred relationship |
Some |
1 |
Phenazone-containing product in otic dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenazone |
Inferred relationship |
Some |
1 |
Product containing only phenazone in otic dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenazone |
Inferred relationship |
Some |
1 |
Product containing precisely phenazone 50 milligram/1 milliliter conventional release ear drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenazone |
Inferred relationship |
Some |
1 |
Product containing precisely phenazone 50 milligram/1 milliliter conventional release ear drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenazone |
Inferred relationship |
Some |
1 |